Robert A. Del Vecchio

668 total citations
14 papers, 522 citations indexed

About

Robert A. Del Vecchio is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Robert A. Del Vecchio has authored 14 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Robert A. Del Vecchio's work include Alzheimer's disease research and treatments (6 papers), Computational Drug Discovery Methods (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Robert A. Del Vecchio is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Computational Drug Discovery Methods (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Robert A. Del Vecchio collaborates with scholars based in United States and France. Robert A. Del Vecchio's co-authors include Lynn A. Hyde, Tatiana M. Kazdoba, Lisa Gold, Timothy J. Kowalski, Eric M. Parker, Galya Vassileva, Eric L. Gustafson, Andrei Golovko, Joseph A. Hedrick and Geoffrey B. Varty and has published in prestigious journals such as Brain Research, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

Robert A. Del Vecchio

14 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Del Vecchio United States 10 227 183 169 120 86 14 522
Yukihiko Hagiwara Japan 17 166 0.7× 217 1.2× 131 0.8× 232 1.9× 59 0.7× 54 737
Ademola O. Oluyomi United Kingdom 8 345 1.5× 165 0.9× 449 2.7× 138 1.1× 78 0.9× 14 736
Rainer O. Heurich United States 5 237 1.0× 260 1.4× 103 0.6× 397 3.3× 40 0.5× 6 635
Sachie Sasaki‐Hamada Japan 15 196 0.9× 117 0.6× 96 0.6× 47 0.4× 54 0.6× 33 487
Michael J. Piesla United States 7 289 1.3× 153 0.8× 120 0.7× 37 0.3× 300 3.5× 7 648
Alessia Costa Italy 14 64 0.3× 300 1.6× 109 0.6× 60 0.5× 130 1.5× 26 559
James E. Koch United States 15 358 1.6× 155 0.8× 106 0.6× 217 1.8× 186 2.2× 19 558
Wiktor Bilecki Poland 16 363 1.6× 297 1.6× 195 1.2× 60 0.5× 48 0.6× 29 681
Raúl Martín‐Ruiz Spain 12 577 2.5× 267 1.5× 82 0.5× 35 0.3× 198 2.3× 13 851
Sandra Dromaint France 7 133 0.6× 188 1.0× 60 0.4× 254 2.1× 49 0.6× 8 426

Countries citing papers authored by Robert A. Del Vecchio

Since Specialization
Citations

This map shows the geographic impact of Robert A. Del Vecchio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Del Vecchio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Del Vecchio more than expected).

Fields of papers citing papers by Robert A. Del Vecchio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Del Vecchio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Del Vecchio. The network helps show where Robert A. Del Vecchio may publish in the future.

Co-authorship network of co-authors of Robert A. Del Vecchio

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Del Vecchio. A scholar is included among the top collaborators of Robert A. Del Vecchio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Del Vecchio. Robert A. Del Vecchio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wu, Wen‐Lian, Duane A. Burnett, John W. Clader, et al.. (2016). Design and synthesis of water soluble β-aminosulfone analogues of SCH 900229 as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(23). 5836–5841. 2 indexed citations
2.
Hyde, Lynn A., Qi Zhang, Robert A. Del Vecchio, et al.. (2013). In Vivo Characterization of a Novel -Secretase Inhibitor SCH 697466 in Rodents and Investigation of Strategies for Managing Notch-Related Side Effects. International Journal of Alzheimer s Disease. 2013. 1–14. 5 indexed citations
3.
Wu, Wen‐Lian, Martin S. Domalski, Duane A. Burnett, et al.. (2012). Discovery of SCH 900229, a Potent Presenilin 1 Selective γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease. ACS Medicinal Chemistry Letters. 3(11). 892–896. 12 indexed citations
5.
Hong, Lan, Galya Vassileva, Li Liu, et al.. (2009). GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. Journal of Endocrinology. 201(2). 219–230. 132 indexed citations
6.
McBriar, Mark D., John W. Clader, Inhou Chu, et al.. (2007). Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 215–219. 37 indexed citations
7.
Kazdoba, Tatiana M., Robert A. Del Vecchio, & Lynn A. Hyde. (2007). Automated evaluation of sensitivity to foot shock in mice: inbred strain differences and pharmacological validation. Behavioural Pharmacology. 18(2). 89–102. 14 indexed citations
8.
Kowalski, Timothy J., Brian D. Spar, Blair Weig, et al.. (2006). Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. European Journal of Pharmacology. 535(1-3). 182–191. 44 indexed citations
9.
Kowalski, Timothy J., Brian D. Spar, Mandy J. Maguire, et al.. (2005). Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. Journal of Endocrinology. 185(1). 151–164. 59 indexed citations
10.
Varty, Geoffrey B., Lynn A. Hyde, Robert A. Hodgson, et al.. (2005). Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species. Psychopharmacology. 182(1). 132–143. 74 indexed citations
11.
Vecchio, Robert A. Del, et al.. (2004). Increased seizure threshold and severity in young transgenic CRND8 mice. Neuroscience Letters. 367(2). 164–167. 83 indexed citations
12.
Varty, Geoffrey B., Robert A. Del Vecchio, Tatiana M. Kazdoba, et al.. (2003). Increased auditory startle response and reduced prepulse inhibition of startle in transgenic mice expressing a double mutant form of amyloid precursor protein. Brain Research. 994(1). 99–106. 29 indexed citations
13.
Benvenga, Mark J., Robert A. Del Vecchio, John F. Capacchione, & Thomas P. Jerussi. (1992). An in vivo alpha-2 assay reversal of opioid-induced muscular rigidity and neuroleptic-induced ptosis. Journal of Pharmacological and Toxicological Methods. 27(1). 45–50. 5 indexed citations
14.
Benvenga, Mark J., et al.. (1991). The discriminative stimulus effect of MK-801 in ketamine-trained rats. Pharmacology Biochemistry and Behavior. 38(1). 211–213. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026